• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Racial disparities in breast cancer survival associated with biologic tumor differences

byMilana Bogorodskaya, MDandPriyanka Vedak
January 14, 2015
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A significant difference in the early diagnosis of breast cancer and mortality was found between non-Hispanic white, black, and Asian women.

2. The majority of the difference was due to differences in biologic characteristics of the tumor – ER and PR-positive tumors were associated with earlier diagnosis, better survival, and were more prevalent in racial groups with more favorable prognosis.

Evidence Rating Level: 2 (Good)       

Study Rundown: The incidence and survival of breast cancer has long been known to vary by racial and ethnic groups in the United States. This study sought to determine whether the disparities were due to differences in early detection or secondary to intrinsic biological characteristics of the tumor. Results showed that the difference in diagnosis of Stage I breast cancer and the 7-year mortality rate between ethnicities was primarily due to the differences in biologic characteristics of the tumor.

Strengths of this study included the large sample size of women in the United States and the inclusion of Asian and Hispanic ethnicities. Although the study controlled for income discrepancies between ethnicities, it did not expand on demographics to assess for differences in access to healthcare, nutritional status and obesity, or differences in diet – variables that may play a role in detecting cancer earlier and reducing mortality. In summary, this study effectively showed that a significant portion of the differences found between ethnicities in regards to early detection of breast cancer and mortality is due to the differences in biologic characteristics of the tumor itself, and less so due to income inequality. By understanding the cause of the differences, more effective strategies can be developed to obtain better outcomes in women of all ethnicities.

Click to read the study, published today in JAMA

Click to read an accompanying editorial, published today in JAMA

RELATED REPORTS

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

Several factors influence health programs conducted in the African American Church

Relevant Reading: Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.

In-Depth [retrospective cohort study]: This is a retrospective cohort study that looked at 373,563 women who were diagnosed with breast cancer between 2004 and 2011. Information regarding ethnicity, race, income, demographics, cancer progression at diagnosis, and biological characteristics of the cancer was collected. Racial and ethnic groups were classified as non-Hispanic white, Hispanic white, black, Chinese, Japanese, South Asian, other Asian, and other ethnicity.

Data analysis showed that Japanese women, compared to non-Hispanic whites, were more likely to be diagnosed with Stage I cancer (OR 1.23; 95%CI 1.15-1.31) while blacks were less likely to be diagnosed with Stage I cancer (OR 0.65; 95%CI 0.64-0.67). Out of all the groups, black women were most likely to be diagnosed at Stage IV. This data correlated with the prevalence of estrogen-receptor (ER) and progesterone-receptor (PR) positive tumors, which were most prevalent in Japanese women and least prevalent in black women. Black women also were most likely to present with triple-negative breast cancers, which has a worse survival rate than cancers that are hormone-positive. Controlling for ER status significantly reduced the difference in mortality and early diagnosis between ethnicities while adjusting for income differences did not.

More from this author: The CLARITY trial: Adding clopidogrel to STEMI management [Classics Series], Aspirin vs warfarin in atherosclerotic intracranial stenosis [Classics Series], The ARISTOTLE trial: Apixaban vs warfarin in atrial fibrillation [Classics Series], The TRITON trial: Prasugrel vs clopidogrel in ACS [Classics Series], Vena caval filters in pulmonary embolism prophylaxis [Classics Series]

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Breast Cancer
Previous Post

Elderly diabetics potentially being over-treated

Next Post

Asthma linked to risk of new-onset obstructive sleep apnea

RelatedReports

2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

June 16, 2022
#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
StudyGraphics

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in  premenopausal women with ER+ breast cancer and ovarian suppression
StudyGraphics

#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression

May 3, 2022
Next Post
Asthma linked to risk of new-onset obstructive sleep apnea

Asthma linked to risk of new-onset obstructive sleep apnea

Four rash patterns common in adults with parvovirus infection

Extended, coordinated approaches were best to teach dermatologic diagnoses

Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery

Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.